PDC Homepage Core Members, Collaborators, and Partners Scientific Divisions & Technological Expertise Outreach & Education PDC Homepage PDC Homepage Contact Information, Feedback

NIH Sponsored Advanced Training Course

Frontiers in Stem Cells
in Cancer

February 5-11, 2017
Morehouse School of Medicine
Atlanta, GA

Application Deadline: December 23, 2016

Register for this Course







Program Organizers:

  • Gerald P Schatten, PhD
    Pittsburgh Development Center

  • Idhaliz Flores, PhD
    Ponce School of Medicine
  • Winston Thompson, PhD
    Morehouse School of Medicine
  • Sponsored by:

    • National Institutes of Health

    • Pittsburgh Development Center of Magee-Womens Research Institute
      at the University of Pittsburgh School of Medicine.


    Group Photo 2013- Ponce, Puerto RicoFRONTIERS IN STEM CELLS IN CANCER (FriSC2), an annual advanced training course, trains promising physician and scientists from predominately underrepresented communities in sophisticated technologies using pluripotent stem cells for clinically relevant discoveries in cancer.  The purpose of this training course is to provide comprehensive and sophisticated training in research strategies and state-of-the-art methods on cellular, molecular and genetic approaches for advancing Cancer Stem Cell Research.

    This NIH sponsored course is designed for young independent scientists, physicians and established investigators. We intend to give students the necessary knowledge of laboratory techniques, career mentoring and the ethical-legal-societal impact of cancer and stem cell research to greatly enhance their successful entry into this field.

    FriSC2 is a dynamic advanced training course that offers a fresh series of daily lecturers on emerging concepts, followed by extended discussion, laboratory research, technologically intense workshops and informal seminars over a week period.  These courses are offered at Howard University in Washington, DC and at Ponce Medical School in Puerto Rico.

    The Stem Cells in Cancer Course will exclusively use human embryonic stem cell lines on the NIH Human Embryonic Stem Cell Registry, which are being routinely cultured at the Pittsburgh Development Center.

    The Stem Cells for the Ponce School of Medicine in Cancer Course were exclusively provided by the NINDS Human Genetics DNA and Cell Line Repository.

    More Information:

    Free Hit Counter
    PDC Home | Faculty | Research | Outreach | Funding | Links | Contact Us

    Last Modified: 28-Oct-2013
    Send comments to